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Literature Review 
  
Developmental Programming 
The once abstract notion that a transient stressor could instill a permanent phenotypic change 
in a developing fetus now enjoys a much more credible reputation. Human epidemiological 
studies have revealed instances in which periods of malnutrition or toxin exposure lead to 
developmental defects in children of exposed pregnant women, and in some cases in subsequent 
generations (Barker, 2004).  Animal studies using rodent and livestock models have expanded on 
these findings, reporting permanent morphologic and functional changes in animals whose dams 
were exposed to various stressors during prenatal development (Allen et al., 2002; Park et al., 
2008; Long et al., 2010; Zhang et al., 2011; Giussani et al., 2012). This adoption of permanent 
structural and physiological changes in response to external stimuli during fetal or early postnatal 
development is known as developmental programming (Reynolds et al., 2009). Phenotype is 
determined by extrinsic environmental stimuli in addition to genetic information, and this 
contradicts the notion that genotype is a rigid blueprint. Rather, developmental plasticity allows 
for the derivation of more than one phenotype from a single complement of genes (Barker, 
2004). Under the theory of developmental plasticity, the object of this process is to mold an 
individual whose traits are best suited to its specific environment. 
Environmental factors include nutrient availability, temperature, the presence of toxins or 
other compounds, and oxygen availability. The intrauterine environment is the source of 
environmental stimuli during fetal development and has been shown to affect the phenotype of 
progeny (Allen et al., 2002; Qasem et al., 2012; Sharma et al., 2012). Embryo-transfer studies 
have demonstrated that the intrauterine environment of the recipient dam may have a greater 
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impact on offspring phenotype than genetic contribution of the embryo donor. Sharma et al. 
(2012) performed such an experiment, using breed as the controlling factor. Single embryos of 
large-breed Suffolk ewes and small-breed Cheviot ewes were transferred within and between 
breeds, creating four treatment groups (Suffolk in Suffolk; Suffolk in Cheviot; Cheviot in 
Cheviot; Cheviot in Suffolk). Large-breed lambs born to small-breed ewes weighed less at birth 
and had smaller body dimensions compared with their counterparts carried to terms in large-
breed ewes.  However, this effect was not observed in small-breed lambs transferred to large-
breed ewes. Allen et al. (2002) performed a similar experiment but used Thoroughbred horses as 
the large-breed genotype and Ponies as the small-breed genotype. Similar to the observations 
made by Sharma et al. (2012), large-breed Thoroughbreds born to small-breed Ponies were 
lighter at birth compared with those born to Thoroughbred mares. In contrast to Sharma et al. 
(2012), Allen et al. (2002) observed decreased birth weights of large-breed foals born to small-
breed mares. The difference in the effect of transferring a small-breed embryo to a large-breed 
dam may be due to species differences. For example, body weight of Cheviot ewes was 77.9% of 
that of Suffolk ewes (Sharma et al., 2012) while Ponies carrying Pony foals weighed only 50.2% 
as much as Thoroughbreds carrying Thoroughbred foals (Allen et al., 2002). 
Two hypotheses were developed to explain the effect of prenatal environment on 
development. The thrifty phenotype hypothesis was first presented and examines the nutritional 
cause of fetal programming, while the predictive adaptive response took a broader approach at 
rationalizing the programming effects caused by a variety of factors. The thrifty phenotype 
hypothesis suggests that a fetus receiving poor nutrition will  prioritize essential body organs at 
the expense of others, resulting in a postnatal metabolic profile that takes advantage of limited 
resources(McMillen and Robinson, 2005). For example, rat fetuses exhibiting intrauterine 
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growth retardation (IUGR), a result of fetal undernutrition, had reduced glucose transport to lung 
tissue while maintaining normal glucose transport to the brain (Simmons et al., 1992). These 
adaptations are homeostatic in nature, making immediate and permanent adjustments to help the 
body overcome impediments that would otherwise reduce survivability (McMillen and 
Robinson, 2005). To determine which traits may be considered thrifty, Qasem et al. (2011) 
restricted maternal protein intake in rats throughout gestation and lactation and measured several 
variables in their offspring. Compared with pups born to control-fed dams, pups from restricted 
dams were heavier, hyperphagic, had a greater feed efficiency, and had greater leptin 
concentrations until day 65 of age. Core body temperature was additionally increased in 
restricted offspring, indicating an increased metabolic rate. These adaptations are meant to create 
an individual that is better suited to cope with decreased protein intake throughout life. The 
authors of this study also reported improved insulin sensitivity in pups of restricted dams, but 
this is in disagreement with other models of IUGR (Simmons et al., 2001; Rozance et al., 2006). 
Decreased insulin sensitivity, or insulin resistance, is characterized by an impaired ability of 
insulin-sensitive tissues to import glucose, resulting in an increase in blood insulin concentration 
without a concomitant decrease in glucose concentration. According to Barker (2004), insulin 
resistance may be a thrifty characteristic because, by reserving glucose in the blood, the brain, 
which has greater priority than other tissues, has greater access to it. However, these studies used 
fetal hypoglycemia (Rozance et al., 2006) and uterine artery ligation (Simmons et al., 2001), 
rather than protein restriction to restrict fetal nutrition. It is therefore possible that protein 
restriction elicits a different set of changes to the intrauterine environment that have a different 
effect on the programming of insulin sensitivity. Insulin resistance has also been reported in 
models of developmental programming caused by maternal obesity and overfeeding (Long et al., 
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2010; Zhang et al., 2010), which the thrifty phenotype hypothesis fails to explain.  
Consequentially, the predictive adaptive response hypothesis was developed to create a more 
universal justification.   
According to the predictive adaptive response, the body uses the intrauterine environment as 
an indication of postnatal conditions and makes adaptations best suited to these forecasted 
conditions (Armitage et al., 2005). In models of maternal overnutrition, intrauterine conditions 
signal to the fetus that nutrients will always be plentiful, and development is directed in such a 
way that creates a phenotype best matched to this scenario. It has additionally been observed that 
fetal programming may result from fetal hypoxia and stress, and this hypothesis can encompass 
these causes as well. The predictive adaptive response hypothesis also explains why certain 
adaptations confer an advantage and others are detrimental.  If the prenatal and postnatal 
environment match, then the individual is well suited to its environment and thrives; on the other 
hand, if the postnatal environment is different, then the individual is not equipped to handle this 
set of conditions and suffers a range of consequences (Armitage et al., 2005). In a reduced 
maternal nutrition model of IUGR, adult rats born to dams on restricted feed during gestation 
weighed less at birth than offspring of ad libitum fed dams (Tosh et al., 2010). When restricted 
offspring were suckled by restricted-fed dams, they weighed the same at 9 months as ad libitum 
offspring suckled on ad libitum-fed dams. However, restricted offspring suckled on ad libitum-
fed dams were heavier, had increased IGF-I expression, and had increased IGF-I serum 
concentrations compared with both other treatments. These rats hadThe negative effects of the 
altered prenatal environment only emerged when the postnatal environment diverged from the 
prenatal environment. 
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Causes of Developmental Programming 
The same conditions found in the postnatal environment (nutrient availability, temperature, 
the presence of toxins or other compounds, or oxygen availability) affect growth in the 
intrauterine environment. The combined effects of these conditions influence fetal development 
by changing fetal nutrition or inducing fetal stress.   
Fetal Nutrition 
Fetal nutrition is critical in directing fetal development. Maternal diet, maternal nutrient 
stores, nutrient delivery to the placenta, and placental transfer of nutrients to the fetal 
compartment determine total fetal nutrition, and a deficit in any of these categories can result in 
impaired fetal nutrition. Maternal under- or overnutrition has been shown to cause changes in 
fetal development.  Blood glucose concentrations decreased in pregnant ewes and in their fetuses 
following a three-day fast, illustrating the relationship between maternal diet, maternal glucose 
concentration, and fetal glucose concentration (Oliver et al., 1993). Pregnant multiparous ewes 
were fed a diet meeting either 100% (control) or 70% (underfed) of daily maintenance 
requirements and differences in growth of singleton fetuses were observed at day 45, day 90, and 
day 135 of gestation. Differences observed at day 45 and 90 were limited and did not always 
carry through to day 135, which may indicate that compensatory gain had occurred in delayed 
organs.. However, at day 135, underfed fetuses were lighter, and had a smaller thoracic girth and 
kidney, gut, heart, and pancreas weight (Osgerby et al., 2002). Although not apparent close to 
term, the brains of underfed fetuses were significantly lighter at day 90 of gestation, which may 
indicate some deficits in neuronal development. Underfed ewes had decreased circulating 
glucose concentrations and a lower body condition score than well-fed ewes, indicating less 
available glucose a smaller reserve for energy mobilization. Differences in placental morphology 
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were also observed in underfed ewes, as their placentas had significantly more D and C type 
placentomes and fewer B type placentomes than well-fed ewes (Osgerby et al., 2002). The C and 
D type placentomes have a greater proportion of fetal tissue to maternal tissue, which has been 
suggested to develop in poor intrauterine conditions to partition more nutrients to the fetus 
(Vonhamme et al., 2006; van der Linden et al., 2012). Whereas Vonhamme et al. (2006) reported 
no differences in vascularity, expression of angiogenic factors, or cell proliferation due to 
placentome morphology, the effect of placentome type on nutrient delivery has not been studied 
directly. Based on this evidence, maternal diet may determine fetal nutrition by simultaneously 
affecting the total substrates available to the fetus and the placental transfer of these substrates.  
The primary response of the fetus to reduced nutrition is to slow cellular division (Barker and 
Clark, 1997). This attempt to preserve what limited nutrients are available may be directly due to 
a lack of nutrients or a response to changes in hormone or growth factor concentrations (Barker 
and Clark, 1997). This deceleration in cellular division has been shown to affect cell distribution 
and organ development. For example, rats that experienced intrauterine growth restriction due to 
bilateral uterine artery ligation had a 50% smaller pancreatic β-cell mass than control rats 
(Simmons et al., 2001). If the affected cells include endocrine tissue such as the pancreas, 
abnormal hormone secretion may ensue, and this can lead to other permanent effects. Reduced 
cell proliferation can therefore continue to affect lifelong growth if it occurs in endocrine organs 
that secrete growth-regulating hormones, including the anterior pituitary gland (growth hormone; 
GH), pancreas (insulin) and liver (insulin-like growth factor I; IGF-I). For example, in 26 week-
old growth-restricted rats exhibiting decreased β-cell masses, serum insulin concentration was 
reduced following a glucose infusion, indicating defects in insulin secretion and action 
(Simmons et al., 2001). Similarly, in an obese ovine model of developmental programming, fetal 
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pancreatic β-cell numbers were reduced by late gestation and lambs of obese ewes had decreased 
circulating insulin and were hyperglycemic at birth (Zhang et al., 2010). 
Increased maternal dietary intake during gestation also affects fetal nutrition and may cause 
developmental programming to occur. Rodent models (Portha et al., 2011) as well as ovine 
models (Long et al., 2010; Adam et al., 2011; Zhang et al., 2011) have revealed detrimental 
lifelong effects in the offspring of overfed mothers. At day 130 of gestation, fetuses of ewes fed 
a high-intake diet from day 35 of gestation were significantly heavier, contained more adipose 
tissue, and had decreased plasma insulin concentrations (Adam et al., 2011). Maternal 
overnutrition may therefore lead not only to increased body weight in the offspring but also to a 
preferential increase in adipose tissue.  Fetuses of overfed ewes also had decreased plasma 
insulin concentrations and alterations to the hypothalamic leptin-signalling pathway. Both insulin 
and leptin are involved in the regulation of metabolism, so alterations to their function have 
implications on feed intake (Coupé et al., 2012), nutrient partitioning (Simmons et al., 2001), and 
tissue development (Thomas et al., 2001; Croze et al., 2012). 
Whereas Adam et al. (2011) investigated the effect of early-gestation overnutrition, Long et 
al. (2010) used an obese overnourished ewe model by overfeeding ewes preconception so they 
were already overweight by embryo implantation.  Ewes were fed either a control (100% NRC 
recommendations) or overfed (150% NRC recommendations) diet from 60 days before 
conception until parturition. Lambs were allowed to nurse from the ewe and were subsequently 
weaned at 120 days of age. There was no effect of maternal overnutrition on offspring body 
weight from birth until 19 months of age. However, following a 12-week feeding challenge, 
offspring of overfed ewes showed significant increases in feed consumption, plasma leptin 
concentration, fasting glucose and insulin concentration, and change in fat mass compared with 
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lambs born to control-fed ewes. This study supports the theory that maternal condition, in 
addition to maternal diet, affects the offspring, since these overfed ewes had increased body 
weights and body condition scores compared with control-fed ewes from conception to 
parturition. A comparison of the studies by Adam et al. (2011) and Long et al. (2010) helps to 
illustrate the importance of the timing of the insult during development. Different tissues and 
organ systems are sensitive to stimuli at different stages of development, and it has been 
hypothesized that this period of sensitivity may be determined by the period of rapid cellular 
development for a specific tissue (Barker and Clark, 1997).  Long et al. (2010) increased 
maternal diet beginning 60 days before conception, while Adam et al. (2011) did not introduce 
the experimental diet until embryo transfer. It may be that only a change in nutrition has a greater 
effect on fetal growth than a preexisting state of poor nutrition. It is also possible that a 
compensatory mechanism accounted for the loss of a difference in fetal weight between day 130 
and birth (approximately day 147). This hypothesis is supported by the observation that there 
was no difference in body weights of 135 day-old fetuses from control- or overfed ewes on an 
identical feeding and breeding regimen to those in the study by Long et al. (Zhang et al., 2011).  
Maternal diet may influence fetal nutrition either directly by a lack or excess of nutrients 
available to the fetus or by impairing placental transfer of these substrates to the fetus. The fetus 
consistently consumes 10% of maternal glucose production, irrespective of decreased maternal 
glucose (Hay et al., 1983). If maternal plasma glucose concentration increases or decreases 
substantially, then the fetus will accordingly acquire an increased or decreased supply of glucose. 
The placenta partitions nutrients between the maternal and fetal compartments, so any defect in 
its structure or function will affect nutrient supply to the fetus. Placental transport of amino acids 
occurs via active transport mechanisms (Oliver et al., 1993). Utero-placental insufficiency has 
 10
been implicated in instances of developmental programming in rodent studies (Portha et al., 
2011). In these studies, fetuses exhibited decreased blood glucose, amino acid, insulin, IGF-I, 
and oxygen concentrations. Uterine artery ligation has been used to model utero-placental 
insuffiency, and fetuses of rats with ligated uterine arteries were lighter at day 20 of pregnancy 
compared with sham-operated rats (Simmons et al., 1992). Maternal overnutrition or obesity may 
contribute to utero-placental insufficiency and this may be a mechanism through which 
overnutrition affects fetal growth. When ewes were fed an obesogenic diet from 60 days 
preconception until necropsy, their fetuses were significantly heavier at day 75 of gestation but 
not different from their control-fed counterparts at day 135, indicating a deceleration in fetal 
growth in the second half of gestation (Ma et al., 2010). Number and weight of all (types A, B, 
C, and D) placentomes were recorded, and cotyledonary (COT) and caruncular (CAR) arteriole 
number, diameter, and angiogenic growth factor expression were measured in two type A 
placentomes in each placenta. The most salient of their findings include an increase in COT 
arteriole diameter in overfed ewes compared with control ewes at day 75 and from day 75 to 135 
in control but not overfed ewes. They also observed a decrease in total and average placentome 
weight in overfed ewes on day 135 compared with control ewes on day 135 and both groups on 
day 75. Blood flow and nutrient exchange are determined by placental vascularity, which is 
affected by arteriole diameter and placentome size. Therefore, these changes may represent a 
delayed compensatory mechanism by the maternal placenta to prevent the influx of excessive 
nutrients and explain the shift in overfed ewes from accelerated growth in early gestation to 
decelerated fetal growth in later gestation. This compensation is likely mediated through the 
altered expression of angiogenic growth factors, as the mRNA abundance of vascular endothelial 
growth factor (VEGF), fibroblast growth factor 2 (FGF-2), platelet-derived growth factor 
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(PDGF), and angiopoietin 1 and 2 (ANG-1,2) were all decreased in overfed ewes compared with 
control ewes at day 75. The juxtaposition of accelerated and decelerated fetal growth may have 
opposite effects on the development of various tissues and organs, depending on their window of 
development, and this may ultimately lead to any the negative consequences of developmental 
programming. 
 
Fetal Stress 
Independent of fetal nutrition, changes to the intrauterine environment may promote 
developmental programming by inducing fetal stress (Barker, 2004). Fetal hypoxia causes a 
reduction in cellular division (Barker and Clark, 1997), providing a potential mechanism by 
which hypoxia and fetal stress causes changes in growth and development. When pregnant rats 
were chronically exposed to hypoxic environments, their 20-day old fetuses exhibited expression 
of 70 kd heat shock protein (HSP70) in cardiac tissue and and aortic wall nitrotyrosine staining, 
both of which are indications of oxidative stress and the presence of reactive oxygen species 
(ROS; Giussani et al., 2012). Chronic fetal hypoxia also significantly increased fetal hematocrit, 
fetal aortic wall thickness, and alterations to adult myocardial contractility in these offspring. 
Maternal supplementation of ascorbic acid, an antioxidant that scavenges ROS, alleviated these 
effects, indicating that oxidative stress is, in fact, the mechanism responsible for programming 
this cardiac dysfunction.   
 
Epigenetics as the Programming Mechanism 
One of the characteristics of developmental programming is the persistence of its effects, 
implying a permanent mechanism of change that occurs without changes to the genome. 
 12
Epigenetic inheritance, a pattern of trait inheritance in which gene expression but not gene 
sequence is changed in response to extracellular stimuli (Ford and Long, 2012), is the likely 
mechanism. Gene expression may be altered epigenetically through DNA methylation at the 5’-
position of cytosine residues within CpG islands or through post-translational histone 
modification. The most common mode of epigenetic control in mammals is DNA methylation of 
cytosine resideues of CpG islands (Ford and Long, 2012). Normally, the embryonic genome is 
demethylated after fertilization, and remethylation begins soon after implantation. Therefore, the 
intrauterine environment during the peri-implantation period is integral in determining the 
remethylation patterns of the genome of the conceptus and affecting development (Wu et al., 
2004).  
Many animal models have supported the role of epigenetics in developmental programming. 
The majority of these are rodent models, and they have shown epigenetic alterations as a result 
of maternal nutritional changes and uterine artery ligation in tissues such as the pancreas, skeletal 
muscle and liver (Park et al., 2008; Raychaudhuri et al., 2008; Thompson et al., 2010; Tosh et 
al., 2010). Pancreatic β-cell dysfunction is a common consequence of intrauterine growth 
retardation. Impaired expression of the transcription factor for β-cell development Pdx1 has been 
implicated in several cases of metabolic syndrome and was observed in IUGR rat offspring (Park 
et al., 2008). Fetuses also exhibited deacetylation of histones H3 and H4 of this gene, while β-
cells of two week-old pups showed methylation on histone 3 lysine 9 (H3K9). Methylation of a 
CpG island followed in adult rats. Histone acetylation is associatied with a more accessible 
chromatin fiber and increased gene transcription while histone methylation decreases 
transcription. Therefore, the epigenetic pattern observed by Park et al. (2008) indicates a 
progressive silencing of the Pdx1 gene. Thompson et al. (2010) expanded on these findings by 
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performing a whole genome cytosine methylation assay on pancreatic islets obtained from 7 
week-old IUGR rat offspring. One thousand loci with significantly different methylation patterns 
between IUGR and control offspring were identified and studied, and these occurred mainly at 
intergenic sequences. Consequentially, it can be concluded that epigenetic modifications are 
involved in the development of permanent changes to the pancreatic islet in response to IUGR. 
Meanwhile, mRNA expression of insulin-sensitive GLUT4 glucose transporters decreased in 
skeletal muscle of female adult rats whose dams received reduced nutrition from day 11 to 21 of 
gestation compared with those born to control dams (Raychaudhuri et al., 2008). Decreased 
GLUT4 activity is one of the factors contributing to insulin resistance and glucose intolerance, 
two components of the metabolic syndrome observed in growth-restricted offspring. In this 
study, several epigenetic control mechanisms were altered, including DNA methyltransferase 
recruitment, histone acetylation and recruitment of glut4 promoter inhibitors and activators. 
Similarly, in the adult liver of IUGR rat offspring fed ad libitum post-natally, mRNA expression 
was increased in several of the IGF-I regions compared with rats born to control dams (Tosh et 
al., 2010). These animals also exhibited decreased rates of H3K4 dimethylation at day 1 of age 
on several of the IGF-I regions. This pattern of dimethylation continued at 9 months of age, at 
which time point trimethylation of H3K4 increased in restricted offspring fed ad libitum post-
natally compared with restricted offspring maintained on a restricted diet. Di- and Trimethylation 
of the H3K4 locus is a marker of increased activated gene expression. These results provide 
additional evidence for a change in gene expression in response to IUGR, possibly manifesting 
as a decrease in IGF-I expression at birth when nutrient supply was low and increasing in early 
postnatal life when nutrient supply increased. Beyond the studies presented thus far, there have 
also been reports of changes in methylation states of glucocorticoid receptor, peroxisome 
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proliferator-activated receptor α (PPAR-α), and angiotensin receptor in rat offspring in response 
to changes in maternal protein intake (Portha et al., 2011). These findings support the theory that 
epigenetic dysregulation is responsible for translating fetal environment to permanent changes in 
phenotype.  
 
Effects in the Offspring 
The effects of developmental programming seen in the offspring are varied and quite often 
interrelated. In general, the effects can be divided into growth pattern alterations, dysregulation 
of metabolism, or organ dysfunction. 
 
Growth Pattern Alterations 
Depending on the timing and nature of the insult to the fetus, growth may be retarded or 
accelerated at various stages during prenatal or postnatal development. Altered postnatal growth 
can be a main effect of developmental programming, while altered prenatal growth can be a 
response to intrauterine conditions that will cause other permanent changes in later life. 
Intrauterine growth retardation falls into a category that is a blend of cause and effect. It is an 
effect of reduced maternal nutrition (Tosh et al., 2010) or reduced utero-placental efficiency 
(Simmons et al., 2001), but it can also cause myriad other lifelong consequences. These 
consequences include, but are not limited to, impaired hormone regulation, insulin resistance and 
gluocose intolerance, altered body composition, and compensatory growth (Simmons et al., 
2001; Osgerby et al., 2002; Ford et al., 2007; Tosh et al., 2010). To understand how IUGR can 
contribute to these effects, it is necessary to understand the importance of mismatch between 
prenatal and postnatal environment. Fetal growth is restricted in response to starvation 
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conditions, and the body is programmed to take advantage of available nutrients as soon as they 
become present. This conditioning persists into postnatal life, and when the offspring is 
presented with adequate nutrition, the body is still programmed to efficiently use as much of the 
substrates as possible, resulting in accelerated growth. This can stress the limits of organs 
designed to meet a reduced functional need (Barker, 2004), leading to other complications. 
Compensatory growth can also occur prenatally when maternal nutrition during gestation is 
restored following a period of restriction (Adam et al., 2011). Lambs whose mothers were fed a 
restricted diet between day 28 and 78 of gestation weighed the same as lambs born to control-fed 
mothers at birth, but trended to be heavier by day 8 and were significantly heavier at 4 months of 
age (Ford et al., 2007). These animals also had greater backfat measurements, greater circulating 
leptin concentrations, and an impaired insulin response to a glucose tolerance test. Although 
restricted lambs did not have reduced birth weights, IUGR is still indicated by the development 
of compensatory growth and other impairments. It is possible that growth was restricted during 
the mid-gestation period of reduced nutrition and then accelerated throughout the last half of 
gestation when proper nutrition was restored.  
However, these changes can occur without the observation of IUGR, and the timing of the 
insult may be the most important factor in determining the observed effects. Ford et al. (2007) 
restricted maternal diet during mid-gestation and observed no effect on birth weight. Meanwhile, 
Tosh et al. (2010) restricted maternal diet of pregnant rats during mid- and late-gestation and 
observed reduced birth weights of IUGR newborns. Both studies reported effects on postnatal 
growth, body composition, and circulating hormones. Intrauterine growth retardation can also 
occur as a result of maternal overfeeding, and this effect is also sensitive to period of 
development. Lambs born to obese ewes that were overfed from pre-breeding until parturition 
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did not differ in birth weight from lambs born to control ewes (Long et al., 2010), while 130-day-
old fetuses from ewes fed a high intake diet from day 35 to 130 were significantly lighter than 
their control counterparts (Adam et al., 2011). 
 
Metabolic Dysregulation 
Animals exhibiting developmental programming often have impaired metabolism regulation 
as indicated by altered circulating hormone concentrations, including insulin, leptin, IGF-I, and 
IGF binding proteins (IGFBP).  
The activity of insulin, an anabolic protein hormone that stimulates glucose-uptake in 
sensitive tissues and is secreted by β-cells of the pancreas, is influenced by developmental 
programming. In vitro glucose-stimulated insulin secretion was significantly reduced in islets 
isolated from ovine fetuses exposed to late-gestation hypoglycemia (Rozance et al., 2009). 
Isolated islets were found to contain normal insulin stores, so the defect in insulin secretion is 
most likely due to a defect in insulin exocytosis rather than synthesis. A rat model of utero-
placental insufficiency-induced IUGR showed similar results (Simmons et al., 2001). At one 
week of age, there was no difference in fasted glucose or insulin concentrations between IUGR 
and control offspring, but fasting hyperglycemia and hyperinsulinema developed in IUGR 
offspring at seven weeks of age. Hyperglycemia continued throughout the study, but the 
hyperinsulinemia regressed after fifteen weeks of age. Glucose tolerance tests and insulin 
tolerance tests at various time points revealed impaired glucose-stimulated insulin secretion and 
impaired glucose clearance in response to insulin, respectively. Rozance et al. (2009) concluded 
that impaired insulin activity is due to a secretory defect, since β-cell numbers remain consistent 
between hypoglycemic and control fetuses. Simmons et al. (2001) also observed similar β-cell 
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mass, as well as islet size and pancreatic weight, between treatment groups at week one and 
seven. However, the relative β-cell mass in 15-week-old IUGR offspring decreased to 50% that 
of control offspring and further decreased to less than one-third that of control offspring by week 
26. Therefore, the insulin resistance and glucose intolerance observed in response to 
developmental programming may be a result of impaired insulin secretion perinatally and a 
conjunction of impaired secretion and reduced β-cell mass later in life. 
The hormone leptin is secreted by white adipose tissue and regulates metabolism by acting on 
specific neurons in the brain that control energy balance (Thomas et al., 2001; Coupé et al., 
2012). Leptin secretion decreases appetite by binding leptin receptors in sensitive nuclei in the 
brain, and it also has peripheral effects (Desai et al., 2007). Fetuses necropsied at day 130 of 
gestation from ewes fed a high intake diet from day 35 of gestation exhibited alterations to the 
leptin-signaling pathway. There was no difference in circulating leptin concentration between 
overfed and control fetus treatment groups, but gene expression of anorexigenic neuropeptide 
(CART) is decreased in the overfed ewe–IUGR fetal group. In addition, in rodents, an early 
postnatal surge in leptin concentrations is thought to program the activity balance in orexigenic 
and anorexigenic neurons and leptin sensitivity (Yura et al., 2005). This peak was also observed 
in lambs, but it was eliminated in lambs born to obese overnourished ewes (Long et al., 2010). 
Defects in leptin regulation may therefore contribute to the increase in adiposity associated with 
IUGR and developmental programming.  
Insulin-like growth factor-I is one component of the somatotropic axis, a group of interrelated 
hormones that regulate growth and metabolism, and which include growth hormone, IGF-I, and 
the IGFBPs. Two neuropeptides from the hypothalamus act on the anterior pituitary gland to 
regulate GH secretion; GH releasing hormone (GHRH) stimulates its secretion while 
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somatostatin (SHRH) is inhibitory.  Once released in circulation, GH binds to its receptor (GHR) 
to stimulate IGF-I release in sensitive tissues and mediate its somatogenic effects through this 
hormone. There are primarily GHR present in liver, and some have also been identified in 
adipose tissue (Sørensen et al., 1992). Insulin-like growth factor-I acts in an endocrine fashion 
when secreted by the liver in response to GH and in an auto- or paracrine manner when secreted 
by select sensitive tissues. The primary action of IGF-I is to promote cellular growth by 
stimulating the synthesis of DNA, RNA, and protein (Clemmons and Underwood, 1991). Muscle 
and bone express IGF-I receptors while adipose tissue does not (Zapf et al., 1978), so increased 
IGF-I concentration preferentially promotes growth of muscle and bone, resulting in a leaner 
animal. While IGF-I is secreted in response to the binding of GH to hepatic IGF-I receptors, 
adequate nutrition is required to increase IGF-I concentrations (Clemmons and Underwood, 
1991; Grant et al., 1973). In humans, reduced cord blood IGF-I concentration is associated with 
preterm growth-restricted fetuses (Chiesa et al., 2008).  Runt piglets, which most likely arise due 
to limited oxygen or nutrient supply, had decreased circulating IGF-I concentrations at birth 
compared with control piglets (Ritacco et al., 1997). Based on these data, it can be concluded 
that IGF-I is important for fetal growth and is sensitive to intrauterine conditions associated with 
developmental programming. Furthermore, liver IGF-I was significantly decreased in newborn 
IUGR rats compared with control pups, but increased significantly compared with control rats by 
adulthood (Tosh et al., 2010). The birth- and adult weights of these animals followed the same 
pattern, so IGF-I may play a role in the mechanism of compensatory growth. 
Six IGFBP control the availability of IGF-I (and IGF-II) to tissues, and these are also affected 
by nutrition (Clemmons and Underwood, 1991). Fetal growth is dependent on IGFBP-2 
concentration, as this is the most abundant IGFBP in fetal blood. Approximately 90% of IGF-I in 
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the blood is bound to IGFBP-3 in a 150 kDa ternary complex that also contains an acid labile 
unit. When bound to IGFBP-3, the half-life of IGF-I is extended from about 10 mintues to 12 
hours, which stabilizes its activity (Kelley et al., 1996). Proper regulation of IGFBP-3 accounts 
for the constant daily concentration of IGF-I. The activity of IGF-I is also influenced by IGFBP-
2 actions, although not to the same extent as IGFBP-3.  There have reports of both inhibitory and 
stimulatory effects of IGFBP-2 on IGF-I. During fetal development, IGFBP-2 is important for 
pituitary development and it remains as the predominant IGFBP in cerebrospinal fluid through 
adulthood. Chronic changes in nutrient intake can influence blood concentration of IGFBP-2 and 
IGFBP-3 (Clemmons and Underwood, 1991). Protein restriction results in increased hepatic 
IGFBP-2 mRNA expression, whereas protein restriction or prolonged fasting decreases IGFBP-3 
concentrations. These patterns have been repeated in models of maternal nutrition–induced 
developmental programming. When ewes were fed a reduced intake diet from day 26 of 
gestation until necropsy, 90-day and 135-day old fetuses had altered circulating concentrations of 
IGFBP-2 and IGFBP-3 (Osgerby et al., 2002). The concentration of IGFBP-2 increased 
significantly from day 90 to day 135 in fetuses from underfed ewes compared with those from 
control-fed ewes, while the concentration of IGFBP-3 only trended to decrease in fetuses from 
underfed ewes. These reports demonstrate that IGFBP-2 and IGFBP-3 respond to changes in 
nutrition.  
There have been reports of changes in GH action in animals exposed to a modified 
intrauterine environment (Costine et al., 2005; Koch et al., 2010). At birth the expression of 
hepatic GH receptors was increased in male offspring of ewes treated with sub-cutaneous GH at 
breeding compared with control lambs (Koch et al., 2010). Hepatic IGF-I expression was 
similarly increased in these animals. Tissue from ewe lambs were not collected in this study, but 
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those from the GH group remained heavier than their control counterparts from birth until 100 
days of age, indicating an effect on postnatal growth and development. Normally, an infusion of 
GH releasing hormone (GHRH) results in an increase in GH concentration, which then 
stimulates IGF-I secretion by the liver. The lambs in this study additionally exhibited an 
attenuated IGF-I response to a GHRH challenge, further substantiating a change to the GH axis.  
Hormone dysregulation is closely related to changes in growth, as concentrations of insulin, 
leptin, IGF-I, and IGFBP all have implications for fetal and postnatal tissue accumulation. 
During fetal development, insulin rather than GH stimulates the release of IGF-I, so insulin and 
IGF-I are therefore both necessary for proper fetal growth (Gluckman and Pinal, 2003). 
Postnatally, insulin promotes tissue accretion. Leptin concenctrations are correlated with body 
weight, body weight gain, body condition score, and carcass fat percentage (Thomas et al., 
2001). Impairment of leptin action can result in an increase in body condition score and carcass 
fat. 
 
Organ Dysfunction 
Non-endocrine tissues can also acquire defects during developmental programming, resulting 
in organ dysfunction. Livestock models of developmental programming have revealed changes 
to the gastrointestinal tract, reproductive tract, brain, kidney, cardiovascular system, and immune 
system (Reynolds et al., 2010). For example, undernutrition of pregnant ewes from day 26 of 
gestation resulted in a reduction in brain weight in 90-day-old fetuses and in gut, kidney, heart, 
and pancreas weight in 135-day-old fetuses compared with fetuses from well-nourished ewes 
(Osgerby et al., 2002). Reductions in organ weight reflect reductions in development, and are 
specific to window of development of each organ. 
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The Relationship Between Maternal Hormones and Developmental Programming 
 The key to understanding how the intrauterine environment induces specific changes in fetal 
development must lie in understanding the changes that occur within the body of the ewe and 
how the embryo or fetus interprets these changes. Maternal hormones regulate metabolism, 
tissue accretion, the availability of nutrients to the fetus, and development of the placenta. 
Therefore, maternal circulating hormones may have an important direct or indirect effect on fetal 
development during gestation. 
Nutrient availability to the fetus determines its capacity for growth. Maternal blood 
composition is one determinant of fetal nutrition, especially in terms of glucose concentration. A 
cascade of events beginning with maternal blood glucose availability affects fetal growth. Fetal 
blood glucose concentration changes concurrently with alterations in maternal blood glucose 
concentration (Oliver et al., 1993; Rozance et al., 2006).  Fetal blood glucose stimulates the 
release of fetal insulin. Whereas GH is responsible for IGF-I secretion by the liver during adult 
life, insulin stimulates the release of IGF-I during fetal life, and IGF-I mediates fetal growth and 
development (Gluckman and Pinal, 2003). When nutrients are scarce, a decrease in fetal insulin 
restricts excess growth to conserve limited nutrients. Changes in maternal glucose concentration 
will lead to changes in fetal glucose concentration, thereby altering the release of insulin and 
IGF-I and affecting growth. As such, hormones that regulate nutrient availability in the mother 
play an important role in determining fetal nutrition and development.  
Insulin is the primary hormone that regulates glucose availability in the mother. In many of 
the animal models reporting evidence of developmental programming in response to changes in 
maternal nutrition, maternal insulin concentration was altered due to changes in plane of 
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nutrition. Ewes fed a high-intake diet had increased circulating insulin concentrations (Adam et 
al., 2011), whereas underfed pregnant ewes had decreased circulating insulin concentrations 
between days 97 and 132 of gestation and decreased glucose concentrations between days 27 and 
132 (Osgerby et al., 2002). It was previously thought that the nutrient demands of the fetus took 
precedence over those of the mother (Barcroft, 1947), so a change in maternal nutrition should 
not affect fetal nutrition or growth even though the needs of the mother may be sacrificed. 
However, the present theory accepts that fetal, maternal, and placental demands are integrated so 
that neither is sacrificed and the survival of both mother and fetus is maximized. In conditions of 
maternal starvation, uptake of maternal glucose is decreased in both the fetal and uteroplacental 
tissues, such that the fetus consistently consumes 10% of maternal glucose production (Hay, 
1983).  
In addition to insulin, concentrations of leptin are sensitive to body composition or nutrient 
intake. Consequentially, leptin may play a role in determining fetal growth in response to 
different levels of nutrition. As gestation progresses, circulating leptin concentrations in the ewe 
decreases (Thomas et al., 2011). This decrease is most likely due to a shift to a catabolic state as 
fat is mobilized from adipose tissue to meet the growing energy needs of the ewe. Changes to 
plane of nutrition lead to changes in leptin concentration. Ewes fed a high-intake diet (i.e., total 
amount in kg/day) have increased concentrations of circulating leptin (Thomas et al., 2001; 
Adam et al., 2011). Leptin mRNA expression, as well as protein concentration, was increased in 
perirenal fat as well (Thomas et al., 2001). When switched from a high-intake to a moderate-
intake diet or vice versa, pregnant ewes exhibited an immediate change in leptin concentration. 
This response may indicate either that leptin has some dependency on diet in addition to body fat 
percentage, or that an interaction with insulin is the cause for the change (Thomas et al., 2001). 
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In rodents, an early postnatal surge in leptin concentrations is thought to program the activity 
balance in orexigenic and anorexigenic neurons and leptin sensitivity (Yura et al., 2005).  This 
same peak was observed in lambs, but it was eliminated in lambs born to obese overnourished 
ewes (Long et al., 2001). It is possible that the elimination of the leptin peak may be the 
mechanism responsible for the effects of developmental programming seen in offspring of 
overfed mothers, but it unclear whether this is a result of alterations in maternal leptin 
concentration or other factors associated with increased body condition. 
The somatotropic axis is additionally affected by maternal nutrition and may mediate fetal 
growth by regulating metabolism as well as placental development. Prolonged fasting is 
associated with increased GH concentrations, resulting from a decreased clearance of GH from 
the blood (Renaville et al., 1992). Ewes treated with GH administration either at breeding or 
during gestation had heavier lambs at birth or near term than control ewes (Costine et al., 2005; 
Koch et al., 2010; Adam et al., 2011). Insulin-like growth factor I regulates glucose and amino 
acid transport across the placenta (Osgerby et al., 2002), so GH mediates placental nutrient 
transport indirectly via stimulation of IGF-I release (Koch et al., 2010). An infusion of GH 
increased maternal blood glucose in pregnant ewes in an overfed model of IUGR (Adam et al., 
2011), so it can consequentially be inferred that an increase in maternal GH can influence fetal 
growth by increasing maternal glucose. In addition to affecting fetal nutrient concentration 
directly, maternal GH affects fetal nutrition through its effect on placental growth. Growth 
hormone administration is reported to enhance placental villus area in sheep (Harding et al., 
1997). This can enhance placental transport, making more nutrients available to the fetus and 
allowing a greater capacity for fetal growth. In addition, treatment with a sub-cutaneous injection 
of GH at breeding significantly affected placental growth in these ewes compared with ewes 
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receiving no GH (Costine et al., 2005). Placental weight of GH-injected ewes significantly 
decreased at 80 days of gestation but returned to normal near term (140 days). At 80 days of 
gestation, a lighter chorioallantois is associated with a more efficient absorption of the 
histotroph, a major source of fetal nutrition at this time (Roberts and Bazer, 1988).  
The effect of nutrition on IGF-I concentrations in pregnant sheep is not entirely clear. 
Concentrations of IGF-I increase throughout gestation, but are not significantly different between 
control and underfed ewes (Osgerby et al., 2002). However, IGF-I concentrations in underfed 
ewes tended to be increased compared with control-fed ewes until day 97 of gestation, when they 
decreased until the end of gestation. However, a 48 h period of maternal starvation significantly 
reduced maternal circulating IGF-I concentration, suggesting that acute changes in diet can affect 
IGF-I concentration (Oliver et al., 1993). There was also a decrease in fetal glucose during this 
period, which strengthens the theory that maternal IGF-I concentrations mediate fetal growth 
through changes in placental glucose transport. However, maternal plasma insulin also fell 
during this period, so it is unclear whether one or both of these hormones played a role in the 
decreased glucose transport, or if the decrease in fetal glucose is solely due to a decrease in 
maternal glucose. It has been shown that treatment with endogenous IGF-I in the pregnant sheep 
promotes fetal growth without increasing placental size, signifying an enhancement of placental 
function (Jenkinson et al., 1999). It is therefore likely that maternal IGF-I influences fetal growth 
by regulating nutrient transport across the placenta. The relationship between maternal nutrition 
and IGF-I concentration needs to be studied further, but an IGF-I decrease due to decreased 
nutrition could restrict placental nutrient transport and consequentially restrict fetal growth.  
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Implications 
It is clear that IUGR is a multi-faceted syndrome, characterized by a range of causes and 
consequences. In a way that mirrors its many-sided nature, IUGR holds implications for more 
than one sector. Specifically, a thorough understanding of IUGR will benefit both animal 
agriculture and human health.  
Animal Agriculture 
One of the goals of animal agriculture is to efficiently produce high quality meat, 
characterized by a high protein and low fat content. Seasonal variation in quality of forage on 
grazing land can result in poor nutrition for pregnant livestock (Ford et al., 2007), resulting in 
compensatory gain and altered body composition later in life. This may have a greater 
implication for industries in which adult weight and carcass composition are particularly 
important. Altered growth patterns in the offspring caused by poor maternal nutrition have been 
shown to result in poor carcass quality in beef and pigs (Rehfeldt et al, 2006; Funston et al., 
2011). An understanding of the causes of IUGR will help producers avoid the negative 
consequences associated with the syndrome, thereby ensuring efficient production of good 
quality meat. 
Human Health 
Developmental programming has been linked to human disease, including obesity, 
cardiovascular disease, insulin resistance, and diabetes (Wu, et al., 2004; Ford, et al., 2005; Tosh 
et al., 2010). It is well known that obesity has become more prevalent than ever in recent years, 
prompting some to refer to it as an epidemic. In the United States, 65% of the population is 
overweight, and half of those are considered obese (Zhang et al., 2010). Cardiovascular disease 
is also widespread, and the National Institute of Child Health and Human Development even 
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cites coronary heart disease as the leading cause of death among men and women (NICHD, 
2003). Although obesity seems to be the major health concern facing this country, maternal 
undernutrition is not absent, and IUGR affects 5% of all U.S.-born infants (Wu et al., 2004). An 
understanding of the mechanisms contributing to developmental programming will help to 
reduce its prevalence and thereby reduce the incidence of these diseases.   
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Materials and Methods 
 
 
Animals 
All procedures were approved by the University of Connecticut Animal Care and Use 
Committee.  
Multiparous Dorset (n = 25), Shropshire (n = 7), and Southdown (n = 4; N = 36) ewes from 
the University of Connecticut flock were used in this study. Estrus was synchronized by the 
placement of a controlled intrauterine drug release (CIDR; Eazi-breed, Pfizer) device containing 
300 mg progesterone for 12 days. A single IM injection of prostaglandin F2α (PGF2α) was 
administered directly following removal of the CIDR. Ewes were placed in three pens separated 
by breed with a single ram from each breed. Once confirmed pregnant by ultrasound, ewes were 
individually penned and randomly assigned to one of three diets (approximately d 31 of 
gestation). Control (CON) ewes received 100% NRC (1985) requirements for a pregnant ewe 
carrying twins, whereas restricted (RES) received 60% and overfed (OVER) received 140% 
requirements. Diets were comprised of a complete pelleted feed and maintained until parturition. 
Daily feed allotments were divided equally between two feeding times, 0800 h and 1600 h daily. 
Feed was weighed before feeding and leftover feed was weighed before the next feeding period 
to determine total intake. Ewes that began to eat their bedding were provided with straw as a 
source of roughage that would not contribute any nutritional value. A handful of straw was also 
mixed into the pellets to prevent ewes from gorging themselves. Ewes were provided with free 
access to water. Ewes were removed from this portion of the study following parturition. 
Ewes were weighed weekly and assigned a body condition score (BCS) between 1 and 5 (1 = 
emaciated, 5 = obese). Blood samples (20 mL) were obtained weekly by jugular venipuncture 
and immediately divided between two (7 mL each) silicone coated glass BD vacutainers, one (3 
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mL) vacutainer containing EDTA and one (3 mL) vacutainer containing heparin. Blood was 
allowed to immediately clot in silicone coated vacutainers at room temperature for 4 to 6 hours, 
then at 4 to 6 °C overnight. These tubes were then centrifugated at 1,200 x. g. at 4 °C for 30 
minutes and serum was immediately pipetted off into two plastic tubes. Vacutainers containing 
anticoagulant were inverted 6 to 8 times immediately following collection, then placed on ice 
until centrifugation at 1,200 x. g. at 4 °C for 30 minutes. Plasma was then pipetted from the 
pellet, and all sample tubes were frozen at -20 °C until hormone analysis.  
 
Hormone Analysis 
 
Growth Hormone 
Serum GH concentrations were determined by radioimmunoassay (RIA) as previously 
described (Kazmer et al., 1992). Lyophilized ovine GH (Purchased from A. F. Parlow, National 
Institute of Diabetes and Digestive and Kidney Diseases, Torrance, CA) was reconstituted and 
labeled with I125 (2 mCi in 20 µL; Cat. # Nez033A002MC, Perkin-Elmer, Shelton, CT). Rabbit-
anti-ovine antibody (Parlow) was used as the First Antibody in 1:20,000 dilution, and goat-anti-
rabbit γ globulin (Cat. # 539845-10KU, Calbiochem, EMD Bioscience) was used as the Second 
Antibody in 1:40 dilution. All samples were analyzed in two assays and run in duplicate. The 
complete protocol can be found in the Appendix. 
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Insulin-like growth factor-I 
Serum IGF-I concentrations were determined by RIA as previously described (Richmond and 
Zinn, 2009) using I125-IGF-I (25 µCi; Cat. # Nex-2410, Perkin-Elmer). Rabbit-anti-human-IGF-I 
(Parlow) was used as the First Antibody in 1:100,000 dilution, and goat-anti-rabbit γ globulin 
(Calbiochem) was used as the Second Antibody in 1:4 dilution. All samples were analyzed 
between three assays and run in duplicate. The complete protocol can be found in the Appendix. 
 
Insulin 
Insulin was analyzed using a colorimetric bovine insulin enzyme-linked immunosorbent assay 
(ELISA; Cat # 80-INSBO-E01, ALPCO Diagnostics, Salem, NH). Serum samples were analyzed 
in duplicate and steps were followed as per manufacturers instructions. Samples from six Dorsets 
that gave birth to twins from each treatment group were analyzed. The OVER group only had 
four Dorsets giving birth to twins, and two Shropshires that gave birth to twins completed this 
group. 
 
Leptin 
Leptin was determined using a commercial multi-species leptin RIA kit (Cat. # XL-85K, 
Millipore Corporation, Billerica, MA). Plasma samples were analyzed in duplicate. Plasma:assay 
buffer ratio was optimized and modified from manufacturers instructions as follows: 300 µL 
sample and 100 µL Assay Buffer were added to sample tubes. Samples were chosen for analysis 
as for insulin. 
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Insulin-like growth factor binding proteins 
Western ligand blot analysis was used for determination of IGFBP concentration as previously 
described (Govoni et al., 2002). A 12 % resolving and 5 % stacking polyacrylamide gel was 
prepared for use in a mini-protean II electophoresis unit (Bio-Rad, Hercules, CA). Each well was 
loaded with 20 µL of prepared sample containing 2 µL serum sample, 18 µL doubly distilled 
water and 20 µL non-reducing load buffer, and samples were run in duplicate. Bovine serum and 
recombinant human IGFBP-3 were used as standards. Proteins were electrophoresed through gel 
at 100 V for 30 minutes and 150 V for 1 hour (until dye reached bottom of gel) then transferred 
to nitrocellulose membrane in a transfer cell (Bio-Rad) at 45 V for 1.5 hours. Membranes were 
incubated in I125-IGF-I overnight in 0.1% Tween 20 in Tris-buffered saline (TBS). Membranes 
were washed after incubation then exposed to a multi-purpose phosphor screen (Packard 
Instrument Company, Meriden, CT) for 18 hours. Phosphor screens were imaged with a Cyclone 
Storage Phosphor Sytesm (Packard) and images were analyzed using OptiQuant acquisition and 
analysis software (Packard). Proteins were measured as digital light units (DLU)/mm2 and 
calculated as a percentage of the signal of the bovine standard. A complete protocol can be found 
in the Appendix. 
 
Data Analysis 
Data were analyzed using ANOVA with SAS Statistical Analysis Software (Cary, NC). All 
longitudinal data were analyzed using the repeated measures method with Proc Mixed. Matrix 
structures were chosen between the Compound Symmetry (CS), Variance Components (VC), 
Autoregressive (AR), Hyun-Feltz (HF), and Toeplitz (TOEP) models by choosing the model 
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with the least AIC. A P-value equal to or less than 0.05 was considered significant, and trends 
were considered as 0.05 < P < 0.10. 
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Results 
 
 
Diet affected average body weight (BW), total gain, and average daily gain (ADG) in 
pregnant ewes (Table 1, Fig. 1). Bodyweight (BW) increased throughout gestation in each of the 
36 ewes in the study. There were no differences in BW due to diet at the onset of treatment (P > 
0.44). By the end of gestation (wk 20), RES ewes (89.3 ± 3.6 kg) were lighter (P < 0.01) and 
OVER ewes (119.7 ± 3.6 kg) were heavier (P < 0.1) than CON ewes (112.9 ± 3.6 kg). Similarly, 
average daily gain (ADG) was increased (P < 0.01) in OVER ewes (0.35 ± 0.01 kg) and 
decreased (P < 0.01) in RES ewes (0.23 ± 0.01 kg) compared with CON ewes (0.27 ± 0.01 kg). 
Average BW throughout gestation was reduced (P < 0.05) in RES ewes (91.4 ± 2.9 kg) 
compared with CON ewes (99.7 ± 2.9 kg). However, despite the increase in late gestation BW 
and ADG, there was no difference (P < 0.4) between average BW of OVER (103.3 ± 2.9) and 
CON ewes. 
Average GH concentration increased from wk 8 to 20 in CON and RES but not OVER 
treatment groups (Table 3). There was no difference between treatment groups until wk 14 (P < 
0.05), at which point GH concentration increased in RES ewes compared with CON ewes. There 
was an overall effect of diet on GH concentration in RES ewes (6.4 ± 0.6 ng/mL), which had 
greater (P < 0.01) concentrations than CON ewes (3.2 ± 0.6 ng/mL) and OVER ewes (2.3 ± 0.6 
ng/mL) over the duration of gestation (Table 2, Fig. 2A).  There was no effect of diet on GH 
concentration in OVER ewes. 
Throughout gestation (wk 8 to 20) average concentrations of IGF-I followed a trend to be 
greater (P < 0.1) in OVER ewes (197.7 ± 14.5 ng/mL) compared with CON (163 ± 14.5 ng/mL) 
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and RES (146.35 ± 14.5 ng/mL) ewes, but there was no difference between CON and RES ewes 
(P < 0.4; Table 2, Fig. 2B). Concentrations of IGF-I did not differ until after approximately wk 
17 of gestation. Overfeeding ewes during gestation resulted in a net increase (60.2 ± 32.9 ng/mL) 
in IGF-I concentration, which was not different from the increase observed in CON ewes (52.7 ± 
32.9 ng/mL). In contrast, RES ewes exhibited a net decrease in IGF-I concentration (-34.9 ± 34.3 
ng/mL), which was different (P < 0.07) from the net change in CON ewes.  
 Concentrations of IGFBP-2 but not -3 were sensitive to changes in diet during gestation 
(Table 2, Fig. 2C, D). Overfeeding ewes resulted in decreased (P < 0.01) IGFBP-2 concentration 
(0.53 ± 0.12 AU) compared with CON ewes (0.97 ± 0.10 AU). There was no effect (P < 0.7) of 
underfeeding ewes on IGFBP-2 concentration (0.93 ± 0.06 AU). Average IGFBP-3 
concentrations were 1.81 ± 0.14, 1.64 ± 0.10, and 1.99 ± 0.14 AU in CON, RES, and OVER 
ewes, respectively, and there were no associated treatment effects (P > 0.3). 
Insulin increased throughout gestation in all treatment groups (Fig. 2E). Average 
concentrations of insulin were greater (P < 0.001) in OVER ewes (0.811 ± 0.06 ng/mL) than 
CON ewes (0.396 ± 0.6 ng/mL; Table 2). There was no effect (P < 0.9) of maternal diet on 
insulin concentration in RES ewes (0.381 ± 0.06 ng/mL). 
 Average concentrations of leptin were greater (P < 0.02) in OVER ewes (4.3 ± 0.6 ng/mL) 
than CON ewes (2.3 ± 0.6 ng/mL; Table 2, Fig. 2F). Leptin averaged 1.5 ± 0.6 ng/mL in RES 
ewes and was not different (P < 0.3) from CON ewes.  
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Table 1.  The effect of feeding a control (CON), restricted (RES) or overfed (OVER) diet on average body 
weight (BW; kg), total BW gain (kg), and average daily gain (ADG; kg) in ewes from wk 8 to 20 of gestation.  
Values are means ± SEM. 
         
Treatment Avg BW (kg) 
P-value 
compared 
with CON 
 
Total gain 
(kg) 
P-value 
compared 
with CON 
 ADG (kg) 
P-value 
compared 
with CON 
         
CON 99.7 ± 2.9   22.8 ± 1.1   0.27 ± 0.01  
RES 91.4 ± 2.9 P < 0.05  10.3 ± 1.1 P < 0.001  0.23 ± 0.01 P < 0.01 
OVER 
 
103.3 ± 2.9 
 
P < 0.4 
 
 
29.3 ± 1.1 
 
P < 0.001 
 
 
0.35 ± 0.01 
 
P < 0.01 
 
 
Table 2.  The effect of feeding a control (CON), restricted (RES) or overfed (OVER) diet 
on concentrations (ng/mL) of metabolic hormones, including GH, IGF-I, insulin, leptin, 
IGFBP-2, and IGFBP-3, from wk 8 to 20 of gestation. Values are means ± SEM. 
 
   
Hormone Treatment Avg concentration (ng/ml) P-value compared 
with CON 
 
   
GH 
CON 3.15 ± 0.56  
RES 6.43 ± 0.56 P < 0.001 
OVER 2.26 ± 0.56 P < 0.3 
 
   
IGF-I 
CON 163.02 ±14.52  
RES 146.35 ± 14.57 P < 0.4 
OVER 197.69 ± 14.50 P < 0.1 
 
   
IGFBP-2 
CON 0.975 ± 0.10  
RES 0.932 ± 0.12 P < 0.7 
OVER 0.533 ± 0.06 P < 0.01 
 
   
IGFBP-3 
CON 1.81 ± 0.14  
RES 1.64 ± 0.1 P < 0.3 
OVER 1.99 ± 0.14 P < 0.3 
 
   
Insulin 
CON 0.316 ± 0.07  
RES 0.309 ± 0.07 P < 0.95 
OVER 0.613 ± 0.07 P < 0.005 
 
   
Leptin 
CON 2.3 ± 0.6  
RES 1.5 ± 0.6 P < 0.3 
OVER 
 
4.3 ± 0.6 
 
P < 0.02 
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Table 3.  The effect of feeding a control (CON), restricted (RES) or overfed (OVER) diet 
on the equations of linear regression line in hormones following a linear trend (i.e. GH and 
leptin).*  
    
Hormone Treatment Equation R2 
 
   
GH 
CON y = 0.14x + 1.27 0.05 
RES y = 0.65x -2.7 0.17 
OVER y = -0.05x + 2.9 0.01 
 
   
Leptin 
CON y = -0.02x + 2.5 0.02 
RES y = -0.04x + 2.0 0.6 
OVER y = 0.09x + 3.2 0.3 
 
   
* y = hormone concentration 
   x = week of gestation 
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Figure 1.  The effect of feeding a control (CON; ♦), restricted (RES; ), or overfed (OVER;) 
diet on body weight (kg) in ewes from wk 8 to 20 of gestation. 
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Figure 2. The effect of feeding a control (CON; ♦), restricted, (RES; ), or overfed (OVER; ) 
diet on average concentrations (ng/mL) of GH (A), IGF-I (B), IGFBP-2 (C), IGFBP-3 (D), 
insulin (E), and leptin (F), from wk 8 to 20 of gestation (x-axis). 
σ  = 0.3 σ  = 210.3 
σ  = 0.01 σ =0.02 
σ  = 0.005 σ  = 0.36 
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Discussion 
 
 
Overall, poor maternal nutrition had an effect on the metabolism of pregnant ewes. 
Underfeeding ewes resulted in decreased BW gain and increased GH concentration, while 
overfeeding ewes led to increased BW gain and insulin, IGF-I, and IGFBP-2 concentration.  
There were no differences in ewe BW at the beginning of the study, with CON, RES, and 
OVER ewes averaging 90.2 ± 2.9, 87.0 ± 2.9, and 90.5 ± 2.9 kg, respectively. Underfeeding 
pregnant ewes decreased their final BW at parturition, while overfeeding increased final BW. 
Underfeeding had a greater effect than overfeeding, as RES ewes gained 12.5 ± 1.1 kg less BW 
than CON ewes throughout gestation, but OVER ewes only gained 6.5 ± 1.1 kg more BW than 
CON ewes. Feeding 140% NRC requirements may not have been enough to elicit a significant 
change in metabolism. Long et al. (2010) fed ewes 150% NRC requirements from 60d prior 
conception, and a significant increase was attained within 60 days. However, the current study 
used an early to late gestation model of poor nutrition rather than a preconception model, and 
some compensatory mechanisms may be in place after conception that reduce the magnitude of 
changes resulting from overfeeding. Many studies utilizing ovine models of fetal programming 
focus on fetal/offspring data rather than maternal BW data (Thomas et al., 2001; Osgerby et al., 
2002; Adam et al., 2001), making it difficult to compare the effects of various nutritional models. 
However, as research in this field continues, it will be necessary to develop clearly defined 
models of fetal programming.  
It is important to note that while there is no difference in BW at wk 8, there is an increase in 
insulin and leptin concentrations in OVER ewes. Ewes began their diet treatments based on an 
estimate of gestational age from ultrasound, but their true gestational age was later calculated 
back from their date of parturition. As a result, some ewes began treatment as early as week 3 
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and as late as week 8 of gestation. To avoid a small sample size, samples were only analyzed 
beginning at week 8, when all the ewes had begun their diets and samples were available from 
each ewe. It is therefore apparent that some of the OVER ewes had been on their increased diet 
before week 8, and this had a moderate effect on insulin and leptin concentrations. Since there 
was no concomitant increase in change in BW at week 8, which suggests that insulin and leptin 
increased in response to a factor independent of BW change. Ruminant pancreatic insulin 
secretion is influenced by a variety of mechanisms, including blood volatile fatty acid (VFA) 
content, physiological state, and subtle stimulatory signals (Harmon, 1992). Leptin concentration 
is proportional to adipose content, so the increase at week 8 may mean that OVER ewes are 
beginning to gain adiposity quickly after the onset of the diet treatment. 
From wk 10 until parturition, RES ewes had greater GH concentrations than CON ewes, in 
agreement with previous studies that have reported increased GH in fasting ewes (Renaville et 
al., 1992). Growth hormone promotes placental growth, and while placental development was 
not evaluated in the present study, this may have been a potential effect of increased GH in RES 
ewes. Enhanced placental development via augmented GH secretion may be an attempt to 
compensate for a lack of nutrients and prevent disturbances to fetal development. However, 
decreased fetal or birth weights most often result from maternal undernutrition (Simmons et al., 
2001; Osgerby et al., 2002; Coupé et al., 2012), so this mechanism is not able to overcome the 
nutrient deficit. 
There was no difference in insulin concentration between RES and CON ewes. During times 
of reduced nutrient availability, glucose uptake is limited in the maternal and uteroplacental 
tissues to maintain a constant supply (10% of maternal glucose production) to the fetus (Hay, 
1983). The reduction change in BW in RES ewes supports the assumption that this was the case 
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in the present study. Since RES ewes showed no change in insulin in circulation, it is likely that a 
decrease in glucose uptake is mediated by a decreased in insulin receptor number or affinity in 
maternal and uterplacental tissues. 
Despite a meager BW change due to overfeeding, overfed ewes showed differences in insulin, 
IGF-I, and leptin metabolism. The increase in insulin concentration is substantial, with the 
average concentration in OVER ewes (0.811 ± 0.06 ng/mL) more than twice the average 
concentration of CON ewes (0.396 ± 14.5 ng/mL). These findings are in agreement with those by 
Zhang et al. (2011), who overfed ewes from 60 d preconception until necropsy at day 135 
(approximately wk 19) of gestation. At day 135, overfed ewes had an insulin concentration of 1.4 
± 0.05 ng/mL, which was double that of control ewes (0.7 ± 0.5 ng/mL). However, in the present 
study, feeding from wk 5 of gestation on resulted in a three-fold increase in insulin (1.14 ± 0.13 
ng/mL in OVER compared with 0.36 ± 0.13 ng/mL in CON ewes) at the same time point (wk 
19). Zhang et al. (2011) supplied overfed ewes with 150% NRC requirements and attained a 
significant difference in BW by conception that was maintained throughout gestation, and still 
did not attain such an increase in insulin concentration. A possible explanation is that 
overfeeding so early allowed the ewes time to adjust to the increased plane of nutrition. 
Meanwhile, the combination of a suddenly increased intake with an increased nutrient demand 
by the placental compartment in the present study may have induced the development of insulin 
resistance in OVER ewes. If increased insulin concentrations in OVER ewes resulted in reduced 
circulating glucose, then the fetus may receive limited nutrition and thereby experience the 
effects of fetal programming. On the other hand, if the ewe is experiencing insulin resistance and 
glucose is not being transported to maternal tissues, then the fetus may in fact receive an 
overabundance of nutrients. It will be necessary in the future to evaluate the state of glucose 
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metabolism to determine which of these processes is occurring and at which point in fetal 
development. 
In sheep, leptin concentration has been shown to be related to nutrition, BW, and adiposity 
(Thomas et al., 2001; Redmer et al., 2012). Increased average leptin concentration in OVER 
ewes could be caused by any or all three of these factors. Leptin concentration follows a negative 
trend in CON and RES ewes, but a positive trend in OVER ewes. Therefore, if leptin is an 
indicator of the metabolic state of the ewe, than it can be concluded that OVER ewes differ from 
CON and RES ewes in that they are in a catabolic state instead of an anabolic one. Increased 
leptin in OVER ewes may have several consequences for the offspring. Leptin receptor has been 
identified in the ovine placenta (Thomas et al., 2001), suggesting that leptin has a role in 
placental development, and this may be one mechanism by which overfeeding influences fetal 
development.  
Circulating concentrations of IGF-I are sensitive to plane of nutrition, so it is intuitive that 
OVER ewes have increased (P < 0.1) IGF-I concentrations. We also expected that RES ewes 
would exhibit decreased IGF-I concentrations, but this was not the case. Similarly, Osgerby et al. 
(2002) reported increasing IGF-I concentrations throughout gestation in restricted and well-fed 
ewes. Since IGF-I responds to chronic changes in nutrition, restricting feed for this time frame 
may not have been long enough to elicit a change. Maternal IGF-I affects fetal glucose 
concentration, likely by a direct effect on transplacental nutrient transport (Jenkinson et al., 
1999). Concentrations of IGF-I in OVER ewes were not different from CON ewes until late 
gestation (after wk 17). This period of gestation is marked by significant fetal growth and limited 
placental growth (Vonnhame et al., 2006). Therefore, lambs born to OVER ewes have most 
likely experienced an influx of glucose during this period of rapid development and will exhibit 
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alterations in tissue accretion and organ development in later life. Indeed, offspring of ewes 
overfed throughout gestation had greater 130-day fetal weights (Adam et al., 2011) and reduced 
kidney and pancreas as a percentage of body weight (Zhang et al., 2011).  
The increase in IGF-I in OVER ewes may be augmented by the activity of IGFBP-2. In the 
present study, IGFBP-2 concentration was decreased in OVER ewes, which is consistent in 
human studies investigating the association between dietary intake and IGFBP concentration 
(Allen et al., 2002; Crowe et al., 2009). In vitro studies have suggested that one of the roles of 
IGFBP-2 is to inhibit the activity of IGF-I (Jones et al., 1995). The decrease in IGFBP-2 in 
OVER ewes would therefore permit an increase in the availability of IGF-I.    
There was no effect of overfeeding ewes on IGFBP-3 concentration. These findings are in 
agreement with those by Crowe et al. (2009), who found no associations between IGFBP-3 
concentration and dietary intake. 
Woodall et al. (1996) reported increased circulating concentrations of IGFBP-2 and 3 in 
underfed pregnant Wistar rats compared with their well-fed counterparts. Both IGFBP-2 and 3 
have inhibitory effects on the activity of IGF-I, so this increase may help reserve limited 
nutrients by restricting IGF-I-stimulated growth. However, in the present study, underfeeding 
pregnant ewes had no effect on either IGFBP-2 or -3 concentration. This may be due to species 
differences or differences in the level of feed restriction. 
Carr et al. (1995) measured IGFBP-3 and IGFBP-2 in the ovine fetus throughout gestation.  
Fetal concentrations of IGFBP-2 increased between early and mid-gestation and declined from 
mid to late gestation. This mirrors the pattern of IGFBP-2 concentration in ewes of the present 
study, which may suggest that maternal IGFBP-2 concentration has a direct effect on fetal 
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IGFBP-2 concentration. There was no such correlation between maternal and fetal IGFBP-3 
concentrations. 
 
In conclusion, poor maternal nutrition alters circulating concentrations of GH, IGF-I, leptin, 
and insulin, and these changes may mediate the effects of fetal programming seen in offspring. 
In underfed animals, placental changes mediated by increased GH are most likely the primary 
hormonal mediator of fetal programming. In overfed animals, leptin also has effects on the 
placenta, and elevated IGF-I promotes fetal growth due to enhanced nutrient transport. The role 
of increased insulin in overfed animals in fetal programming will remain unclear until the 
relationship between insulin and glucose in the ewes can be determined. 
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Appendix 
 
GH RIA Protocol 
 
Solutions: 
1M Dibasic phosphate buffer 
Compound Amount 
Dibasic NaH2PO4, anhydrous  
(FW 141.96 g) 
141.96 g 
dH2O 1.0 L 
 
1M Monobasic phosphate buffer 
Compound Amount 
Monobasic NaH2PO4, anhydrous 
(FW 119.96) 
119.96 g 
dH2O 1.0 L 
 
0.5 M Phosphate Buffer, pH 7.4 
 Combine monobasic and dibasic phosphate buffers until pH reaches 7.4 and volume is 
approximately 1.0 L. Previously this was achieved by combining 150 mL Monobasic 
with 850 mL Dibasic for a total volume of 1 L. 
 
Assay Buffer 0.1% BSA, pH 7.4 
 45
Compound Amount 
0.5 M Phosphate Buffer 100.0 mL 
Bovine serum albumin (BSA) 1.0 g 
NaCl 8.9 g 
dH2O qs to 1.0 L 
 
First Antibody Buffer 
Compound Amount 
Normal rabbit serum (NRS) 0.25 mL 
EDTA 1.86 g 
Assay Buffer 0.1% BSA qs to 100 mL 
 
First Antibody (1:20,000) 
 Rabbit anti-ovine GH, lyophilized 
 A. F. Parlow, NIDDK, Torrance, CA 
 
1. Reconstitute lyophilized antibody with dH2O  
2. Add 400 µL antibody to 80 mL First Antibody Buffer to attain 1:20,000 dilution 
 
Second Antibody Buffer, pH 7.4 
Compound Amount 
0.5 M Phosphate Buffer 100 mL 
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EDTA 18.6 g 
PEG 8000 (Carbowax) 50 g 
dH2O qs to 1.0 L 
 
Second Antibody (1:40) 
 Goat-anti-rabbit γ-globulin  
 A. F. Parlow, NIDDK, Torrance, CA 
 Contains 125 units i.e. 12,500 µL γ-globulin reconstituted 
 0.5 unit (50 µL) antibody will precipitate the γ-globulin in 100 µL of 2% normal rabbit 
serum (NRS) 
 
1. Reconstitute lyophilized goat-anti-rabbit γ globulin with 12.5 mL ddH2O (no dilution) 
2. Add 1 mL antibody to 39 mL Secondary Antibody Buffer to attain 1:40 dilution 
 
GH Standard 
 Ovine GH, lyophilized 
 A. F. Parlow, NIDDK 
 
1. Reconstitute lyophilized ovine IGF-I to 40 ng/µL 
 
Day 1: 
1. Prepare standard curve 
a. 8 point curve  
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b. Quadruplicates of each point 
c. Beginning with 40 ng/mL stock solution, serially dilute to create curve: 
i. 0.1 ng/mL, 0.25 ng/mL, 0.5 ng/mL, 1 ng/mL, 2.5 ng/mL, 5 ng/mL, 10 
ng/mL, 20 ng/mL 
2. Add 200 µL sample, pool, or standard to glass tubes 
3. Add 300 µL Assay Buffer to standard, control, and sample tubes 
4. Add 500 µL Assay Buffer to NSB and TB tubes 
5. Add 100 µL First Antibody Buffer to NSB tubes 
6. Add 100 µL I125-GH to all tubes (20,000 cpm per tube) 
7. Add 100 µL First Antibody to all tubes except NSB and TC 
8. Vortex tubes 1-2 minutes 
9. Cover tubes with tin foil and incubate at room temperature for 24 hours 
 
Day 2: 
1. Prepare Second Antibody 
2. Add 400 µL Second Antibody into all tubes except TC  
a. Stagger this step so that tubes can be centrifuged immediately after incubation 
period (i.e. if centrifuge only holds 100 tubes add antibody in groups of 100 
tubes) 
3. Vortex tubes 1-2 minutes 
4. Incubate at room temperature for 1 hour 
5. Centrifuge tubes (except TC) at 3,000 rpm for 30 minutes 
6. Decant tubes (except TC) and allow to dry upside down overnight on absorbent paper 
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Day 3: 
1. Count radioactivity on gamma counter (Perkin-Elmer) 
 
Calculations 
1. Calculate average CPM for TC, NSB, TB, standards, pools, and samples 
2. Calculate percent binding for TB, standards, pools, and samples 
a. % binding = (CPM – CPMNSB) / (CPMTC – CPMNSB) 
b. Total binding (TB) should be over 15% 
3. Construct standard curve using % binding for standards 
a. Plot log(ng/mL) v. % binding 
b. Perform linear regression to obtain standard equation (CPM = a*log(ng/mL) + b) 
4. Calculate ng/tube from standard equation 
5. Calculate ng/mL by multiplying ng/tube by dilution factor (5) 
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IGF-I RIA Protocol 
 
Solutions: 
 
Assay Buffer, pH 7.5 
Compound Amount 
Tris HCl 14.04 g 
Tris Base 1.34 g 
Tween 20  2.0 mL 
Disodium EDTA 7.4 g 
Phenol Red 0.04 g 
ddH2O qs to 2 L 
 
1) Mix all reagents except Tween 20 and filter using Corning filter into 2 L Pyrex bottle. 
2) Add Tween 20 and set pH to 7.5. 
3) De-gas buffer overnight. 
 
**After buffer has been de-gased, be very cautious when handling it so as to not reincorporate 
air bubbles into the mixture.  Pour very slowly into containers, and never use a funnel. 
 
Assay Buffer (0.25% BSA) 
 
Compound Amount 
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Assay Buffer (No BSA) , pH 7.5 1 L 
BSA (RIA grade) 2.5 g 
 
1) Pour buffer into beaker, then add BSA (so it doesn’t stick to glass).  
2) Allow BSA to dissolve, then mix.  (Do not spin stir bar too fast or else it will create 
bubbles) 
 
Extraction Buffer (0.05% BSA) 
Compound Amount 
Assay Buffer (No BSA),  pH 7.5 2 L 
BSA (RIA grade) 1.0 g 
 
 Mix as described for 0.25% BSA Assay Buffer 
 
Carbowax Solution 
Compound Amount 
PEG-8000 (Carbowax) 8.56 g 
Assay Buffer (No BSA) qs to 200 mL 
 
 
0.2M Glycylglycine, pH 2.1 
Compound Amount 
Glycylglycine HCl 3.372 g 
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ddH2O 100 mL 
 
 
Carrier Solution 
 Normal Rabbit Serum (NRS), lyophilized solid 
 Cat. # 869019, Calbiochem, La Jolla, CA 
1. Reconstitute to 5 mL with ddH2O 
2. Add 500 µL NRS to 49.5 mL Assay Buffer to attain 1:100 dilution 
 
First Antibody (1:100,000) 
 Rabbit-anti-human-IGF-I, lyophilized 
 A. F. Parlow, NIDDK 
 
1. Reconstitute with 500 µL dH2O to make a 1:10 dilution 
2. Prepare 1:100,000 dilution 
a. Add 500 µL reconstituted antibody to 2.0 mL Assay Buffer to make a 1:50 
dilution 
i. These were stored in aliquots in -80 °C freezer 
b. Add 25 µL (1:50) antibody to 49.975 mL Assay Buffer 
c. pH should be similar to Assay Buffer (7.5) 
 
Second Antibody (1:4) 
 Goat-anti-rabbit γ-globulin, A. F. Parlow, NIDDK 
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 Contains 125 units i.e. 12,500 µL antibody reconstituted 
 1 unit (100 µL) antibody will precipitate the γ-globulin in 200 µL of 2% normal rabbit 
serum (NRS) 
 
1. Reconstitute lyophilized goat-anti-rabbit γ globulin with 12.5 mL ddH2O 
2. Add 5 mL reconstituted Second Antibody to 15 mL Carbowax Solution to attain a 1:4 
dilution 
 
IGF-I Standard 
 Ovine IGF-I, lyophilized 
 A. F. Parlow, NIDDK 
 
2. Reconstitute lyophilized ovine IGF-I to 200 ng/µL 
3. Bring to 5 ng/mL in Assay Buffer (0.25% BSA) 
 
I125-IGF-I 
 Final activity 10,000 cpm/100 µL 
 Received lyophilized 25 µCi 
 Cat. # Nex-2410, Perkin Elmer, Shelton, CT 
 
1. Reconstitute lyophilized with 500 µL dH2O 
2. Count 5 µL to determine cpm/µL 
3. Add Assay Buffer (0.25%) until activity is 10,000 cpm per 100 µL 
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i. 8 point curve containing quadruplicates of 10 ng/mL, 20 ng/mL, 40 
ng/mL, 80 ng/mL, 160 ng/mL, 320 ng/mL, 640 ng/mL, and 1280 
ng/mL 
Day 1: 
1. Pipette 100 µL sample and pools into plastic tube 
2. Pipette 100 µL Glycylglycine into each tube 
3. Vortex 1-2 minutes 
4. Cap tubes 
5. Incubate at room temperature 36 hours 
Day 3: 
1. Extract samples 
The final result will consist of 25 µL extracted sample and 175 µL Assay Buffer 
(0.25%). This is accomplished using a Digiflex CX pipetting station (Titertek 
Instruments, Huntsville, AL). 
a. Add 1 mL Extraction Buffer to sample  
i. Vortex  
ii. Repeat twice 
iii. With each addition of buffer sample should turn yellow to orange to pink 
b. Using pipetting station, add 25 mL of sample to 2 tubes, followed by 175 µL 
Assay Buffer (0.25%) 
i. Do this quickly so that IGFBP do not re-anneal to IGF-I 
2. Set up assay 
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a. Prepare standard curve 
i. Beginning with 1280 ng/mL stock solution, serially dilute to create curve: 
1. 10 ng/mL, 20 ng/mL, 40 ng/mL, 80 ng/mL, 160 ng/mL, 320 
ng/mL, 640 ng/mL, and 1280 ng/mL 
2. Add 200 µL each standard to tubes in quadruplicate 
b. Add 300 µL Assay Buffer (0.25%) to NSB tubes 
c. Add 200 µL Assay Buffer (0.25%) to TB tubes 
d. Add 100 µL I125-IGF-I into all tubes 
3. Vortex tubes 1-2 minutes 
4. Cover tubes with tin foil and incubate at room temperature for 24 hours 
Day 4: 
1. Add 100 µL I125-IGF-I to each tube 
2. Vortex 1-2 minutes 
3. Cover with tin foil and incubate at 4 °C for 48 hours 
 
Day 6: 
1. Add 400 µL Second Antibody to all tubes except TC (no need to stagger) 
a. Vortex tubes 1-2 minutes 
b. Incubate at 4 °C for 1 hour 
2. Add 100 µL Carrier Solution to all tubes except TC 
a. Vortex 1-2 minutes 
b. Incubate at 4 °C for 1 hour 
3. Centrifuge tubes (except TC) at 4.000 rpm for 30 minutes 
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a. Centrifuge in groups of tubes that can be aspirated in less than 5 minutes 
4. Aspirate liquid from pellet, being sure not to disrupt pellet 
5. Dry uncovered overnight 
6. Count radioactivity on gamma counter (Perkin-Elmer) 
 
Calculations 
1. Calculate average CPM for TC, NSB, TB, standards, pools, and samples 
2. Calculate percent binding for TB, standards, pools, and samples 
a. % binding = (CPM – CPMNSB) / (CPMTC – CPMNSB) 
b. Total binding (TB) should be over 15% 
3. Construct standard curve using % binding for standards 
a. Plot log(ng/mL) v. % binding 
b. Perform linear regression to obtain standard equation (CPM = a*log(ng/mL) + b) 
1. Calculate ng/mL from standard equation 
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IGFBP Western ligand blot 
 
Solutions: 
 
Resolving Gel Buffer (1.5 M Tris + 0.4% SDS) pH 8.8 
Compound Amount 
Tris (MW 121.12 g) 90.855 g 
Sodium dodecyl sulfate (SDS) 2.0 g 
ddH2O qs to 500 mL 
 
Stacking Gel Buffer 
Compound Amount 
Tris (MW 121.12 g) 30.285 g 
SDS 2.0 g 
ddH2O qs to 500 mL 
 
Acrylamide 30 % (Neurotoxin) 
Compound Amount 
Acrylamide 60.0 g 
bis Acrylamide 1.6 g 
ddH2O qs to 200 mL 
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 Dissolve first in 100 mL dd H2O, then qs to 200 mL 
 Filter after preparing solution 
 Store at 4 °C in dark jar 
 
Persulfate 14% 
Compound Amount 
Persulfate 0.07 g 
ddH2O 500 µL 
 
 Newly made persulfate lasts about 8 hours 
 
Non-reducing Load Buffer 
Compound Amount 
SDS 0.8 g 
Glycerol 4.0 mL 
Bromophenol blue Enough to color solution 
ddH2O qs to 20 mL 
 
 
Tank Buffer 
Compound Amount 
Glycine 14.4 g 
Tris Base 3.0 g 
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SDS 1.0 g 
ddH2O qs to 1.0 L 
 
 
Towbin Buffer 
Compound Amount 
Glycine 28.83 g 
Tris Base 6.06 g 
SDS 0.6 g 
Methanol 400 mL 
ddH2O 1600 mL 
 
 
Tris-buffered saline (TBS) 
Compound Amount 
Tris HCl 1.58 g 
NaCl 8.77 g 
Sodium Azid 0.5 g 
ddH2O qs to 1.0 L 
 
 
TBS + 1% Tween 
Compound Amount 
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Tween 20 10 mL 
TBS 990 mL 
 
 
TBS + 1.0% Tween 
Compound Amount 
Tween 20 1 mL 
TBS 999 mL 
 
 
TBS + NP40 
Compound Amount 
NonIDET P40 (NP40) 30 mL 
TBS 970 mL 
 
 
Polyacrlylamide gel electrophoresis: 
1. Prepare resolving gel 
a. Use 10% ethanol to clean glass plates 
b. Set up plates in gel box 
c. Prepare resolving gel by mixing reagents in the order as follows: 
Compound Amount 
ddH2O 27.8 mL 
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Resolving gel buffer 20.1 mL 
Acrylamide 31.8 mL 
Persulfate 302 µL  
Temed 50 µL  
 
d. Immediately pour gel into gel box, filling up to 1 cm below the comb line 
e. Tap gel box to remove any air bubbles: lift one edge of gel box about 1 cm and 
gently drop 
f. Immediately pipette 300 µL ddH2O between each plate 
g. Allow gel to polymerize (approximately 1 hour) 
h. Note: gel may be premade night before running gels. If this is done, pipette 500-
700 µL ddH2O between plates and set gel box in refrigerator (2-6 °C) overnight. 
2. Prepare stacking gel 
a. Use 10% ethanol to clean gel combs 
b. Place chromatography paper slips into space between gel plates to wick away all 
ddH2O (without touching resolving gel) and remove once all water is gone 
c. Prepare stacking gel by mixing reagents in the order as follows: 
Compound Amount 
ddH2O 17.4 mL 
Resolving gel buffer 7.6 mL 
Acrylamide 5.0 mL 
Persulfate 150.8 µL  
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Temed 15.8 µL  
 
d. Pour gel into gel box 
e. Immediately insert well combs between gel plates 
f. Allow gel to polymerize (approximately 1 hour) 
3. Set up gel cartridges 
a. Remove gels on at a time from gel box 
b. Pull combs straight out of each gel  
c. Rinse each gel with dH2O 
d. Clamp two gels into a single gel cartridge 
4. Prepare samples and standards 
a. Mix as follows in microcentrifuge tubes: 
i. Samples 
1. 2 µL serum 
2. 18 µL ddH2O 
3. 20 µL load buffer 
ii. Recombinant human IGFBP-3 
1. 6 µL standard 
2. 114 µL ddH2O 
3. 120 µL load buffer 
iii. Bovine 
1. 32 µL serum 
2. 128 µL ddH2O 
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3. 160 µL load buffer 
b. Briefly centrifuge microcentrifuge tubes 
c. Incubate tubes in 60 °C water bath for 10 minutes 
d. Briefly centrifuge microcentrifuge tubes 
5. Load gels 
a. Fill gel cartridge with tank buffer 
b. Load 20 µL of sample or standard into each well 
i. Do not use very first or last well and always load human standard into first 
lane used, followed by bovine standard 
c. Load gel cartridges into running tank 
i. Turn on water for cooling and turn on stir bar 
6. Connect tank to voltage source and turn to 150 V. Run for 1.5 hours or until dye has 
reached bottom of gel. 
 
Transfer to Nitrocellulose 
1. Remove gels  
a. Remove cartridges from tank 
b. Separate gel plates 
c. Cut stacking gel and excess gel away from resolving gel 
2. Form transfer sandwich: 
a. Chromatography paper 
b. Gel 
c. Nitrocellulose membrane (label gel ID in upper left corner with pen) 
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d. Chromatography paper 
e. Make sure there are no bubbles between layers 
3. Place sandwiches in transfer cartridge (gel side down on black side of cartridge) 
4. Load transfer cartridges into transfer cell (black side of cartridge should face negative 
terminal) 
a. Fill cell with Towbin buffer 
b. Add cooling loop with running water 
c. Add stir bar and place on stir plate – spin enough to circulate water but not create 
turbulence 
5. Connect to power supply and run at 45 V for 1.5 hours 
6. Remove nitrocellulose and dry between chromatography paper sheets (at least 20-30 min) 
Proceed directly to next step or wrap gels individually in tin foil and freeze in -20 °C 
freezer until washing 
 
Tracer and Blocking: 
Before starting, make sure phosphor screen has been exposed to light for at least 5 hours 
1. Place each membrane in its own Tupperware container 
2. Add 15 mL TBS + NP40 
a. Place on shaker at 100 – 150 rpm for 15 min 
b. Pour down drain 
3. Add 15 mL TBS + 1% Tween  
a. Place on shaker at 100 – 150 rpm for 2 hours 
b. Pour down drain 
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4. Add 10 mL TBS + 0.1% Tween and enough I125-IGF-I to obtain 300,000 cpm per blot 
a. Do not touch radioactivity directly to blot – tip Tupperware slightly and add to 
liquid away from blot 
b. Place on shaker at 100 – 150 rpm for 15 hours 
c. Pour down drain with copious amounts of water 
5. Add 15 mL TBS + 0.1% Tween 
a. Place on shaker at 100 – 150 rpm for 15 min 
b. Pour down drain 
6. Repeat 
7. Add 10 mL TBS  
a. Place on shaker at 100 – 150 rpm for 10 min 
b. Pour down drain 
8. Repeat twice 
9. Place blot on filter paper and dry (at least 20-30 minutes) 
10. Wrap blots in saran wrap and place on phosphor screen 
11. Incubate with screen in the dark for 18 hours 
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